Takeda Pharmaceutical Ordered to Pay $885 Million for Antitrust Violations

A Massachusetts jury ordered Takeda to pay $885M in antitrust damages over a pay-for-delay deal, tripling to $2.65B unde...

EPO revokes another Novo Nordisk patent behind Ozempic and Wegovy drugs

Novo Nordisk's semaglutide patents hit by EPO revocation in obesity drug dispute. EP 2 866 825 invalidated for lacking i...